Jahanara Rajwani

5PUBLICATIONS
45CO-AUTHORS
Gene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 01, 2026
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

|Jul 22, 2025
The human STING agonist E7766 induces immunogenic tumor clearance, independent of tumor-intrinsic STING expression in the KRASG12D/+ Trp53-/- murine model of sarcoma.

Karys M Hildebrand, Kurt N Hildebrand, Carolina Salazar Arcila

|Nov 15, 2024
VSV∆M51 drives CD8+ T cell-mediated tumour regression through infection of both cancer and non-cancer cells.

Jahanara Rajwani, Daniil Vishnevskiy, Madison Turk

|Nov 01, 2024
The pore-forming apolipoprotein APOL7C drives phagosomal rupture and antigen cross-presentation by dendritic cells.

Gerone A Gonzales, Song Huang, Liam Wilkinson

|Jul 09, 2021
The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.

Karys M Hildebrand, Arvind K Singla, Reid McNeil

Pageof 1

Frequent Collaborators

2 joint publications

Jennifer Chan

2 joint publications

Douglas J Mahoney

2 joint publications

Saif Sikdar

2 joint publications

Karys M Hildebrand